This Speaker Series focuses on two presentations recently given at Australian Gastroenterology Week
(AGW), Adelaide Convention Centre, Adelaide, SA; 10–12 October. AGW is the annual scientific meeting
of the Gastroenterological Society of Australia, and is the principal forum in Australia where clinicians
and scientists engaged in gastroenterology and hepatology can meet, learn, and share ideas. AGW 2016
delivered a comprehensive overview of the latest information, insights and practices in gastroenterology,
endoscopy, surgery and hepatology over three days of scientific and educational sessions.
The presentations outlined in this review were given by Dr Fraser Cummings (Consultant Gastroenterologist,
Southampton, England) and Professor Jørgen Jahnsen (Akershus University Hospital, Oslo, Norway).
Dr Cummings addressed clinical experience in Southampton attained with switching IBD patients from
originator to biosimilar infliximab. Prof. Jahnsen outlined similar experience in Norway.
Please login below to download this issue (PDF)